stdClass Object
(
    [id] => 16473
    [paper_index] => 202506-02-022303
    [title] => FORMULATION AND EVALUATION OF ECZEMA CREAM
    [description] => 
    [author] => Mr. Vaibhav S. Chatur, Mr. Swapnil Kulthe
    [googlescholar] => 
    [doi] => 
    [year] => 2025
    [month] => June
    [volume] => 10
    [issue] => 6
    [file] => fm/jpanel/upload/2025/June/202506-02-022303.pdf
    [abstract] => Atopic Dermatitis, commonly known as eczema, is a common chronic, relapsing skin disease characterized by pruritus, disrupted epidermal barrier function, and immunoglobulin e- mediated sensitization to food and environmental allergens. AD is often called the “itch that rashes” because the itching starts, and then the skin rash follows as a result of scratching. This eczema can cause two types of pigmentation changes that are, Hypopigmentation and Hyperpigmentation. Eczema is a complex disease that arises from interaction between genes and environment. There are 3 classical stages of eczema: infantile, childhood, 1and adulthood. Eczema is a type of condition that causes skin inflammation. Therefore, topical preparations are at core of eczema treatment; these includes topical moisturizers, topical corticosteroids, and topical calcineurin inhibitors. However, even with careful treatment, eczema is likely to relapse.
    [keywords] => Atopic dermatitis(AD), Pruritus, Chronic skin disorder, Topical preparations, skin inflammation
    [doj] => 2025-06-09
    [hit] => 
    [status] => 
    [award_status] => P
    [orderr] => 35
    [journal_id] => 2
    [googlesearch_link] => 
    [edit_on] => 
    [is_status] => 1
    [journalname] => EPRA International Journal of Research & Development (IJRD)
    [short_code] => IJSR
    [eissn] =>  2455-7838 (Online)
    [pissn] => - -
    [home_page_wrapper] => images/products_image/2-n.png
)
Error fetching PDF file.